RBC Capital Initiates Icon PLC(ICLR.US) With Buy Rating, Announces Target Price $263

加皇資本市場首次給予Icon PLC(ICLR.US)買入評級，目標價263美元

moomoo資訊 · 01/07 06:31 · 評級/大行評級

RBC Capital analyst Sean Dodge initiates coverage on $Icon PLC (ICLR.US)$ with a buy rating, and sets the target price at $263.

According to TipRanks data, the analyst has a success rate of 40.6% and a total average return of -6.2% over the past year.

AnalystRecentRatingAutoNews_206228_20250106_4309201c7a016eb8d6120aec317c34dec0966bdc_1736253003157542_mm_en

Furthermore, according to the comprehensive report, the opinions of $Icon PLC (ICLR.US)$'s main analysts recently are as follows:

Anticipations for key themes in the life science tools and diagnostics sector include the pace and scale of anticipated recoveries in areas such as China and bioprocessing, the initiation of stimulus programs in China, trends affecting the instrumentation replacement cycle, the overall health of biopharma and its potential influence on clinical trial demand, and the likely impacts of the new administration. Adjustments have been made to reflect decreased margins due to pass-through effects.
As one of the biggest global contract research organizations, Icon assists its biopharma clients in accelerating the drug market entry process. Recently, the company's shares have dropped 25% owing to several temporary factors that impacted near-term earnings growth and investor mood. It is anticipated that as these obstacles diminish, there will be a significant resurgence in earnings growth, potentially enhancing Icon's market valuation.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

加皇資本市場分析師Sean Dodge首次給予$Icon PLC (ICLR.US)$買入評級，目標價263美元。

根據TipRanks數據顯示，該分析師近一年總勝率為40.6%，總平均回報率為-6.2%。

AnalystRecentRatingAutoNews_206228_20250106_4309201c7a016eb8d6120aec317c34dec0966bdc_1736253003157542_mm_tc

此外，綜合報道，$Icon PLC (ICLR.US)$近期主要分析師觀點如下：

對生命科學工具和診斷領域關鍵主題的預期包括中國和生物加工等領域的預期復甦速度和規模、中國刺激計劃的啓動、影響儀器更換週期的趨勢、生物製藥的整體健康狀況及其對臨牀試驗需求的潛在影響，以及新政府可能產生的影響。已進行了調整，以反映由於直通效應而導致的利潤減少。
作爲最大的全球合同研究機構之一，ICON協助其生物製藥客戶加快藥品市場進入過程。最近，由於影響短期收益增長和投資者情緒的幾個臨時因素，該公司的股價下跌了25％。預計隨着這些障礙的減少，收益增長將大幅回升，這有可能提高ICON的市場估值。

提示:

TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。

TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。

分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。

總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

RBC Capital Initiates Icon PLC(ICLR.US) With Buy Rating, Announces Target Price $263

RBC Capital Initiates Icon PLC(ICLR.US) With Buy Rating, Announces Target Price $263

風險及免責聲明

聲明